Guanfacine is not an SSRI. It belongs to a completely different drug class called alpha-2 adrenergic receptor agonists, and it works on a different neurotransmitter system than any SSRI. The two medications have different uses, different mechanisms, and different side effect profiles.
What Guanfacine Actually Is
Guanfacine is a selective central alpha-2A adrenergic receptor agonist. In plain terms, it targets specific receptors in the brain that respond to norepinephrine, a chemical messenger involved in attention, impulse control, and blood pressure regulation. It has 15 to 20 times higher affinity for the alpha-2A receptor subtype than for related subtypes, which makes it quite targeted in how it works.
The extended-release form, sold under the brand name Intuniv, is FDA-approved to treat ADHD in children and adolescents. The immediate-release form has been used for decades to treat high blood pressure. It works by decreasing heart rate and relaxing blood vessels so blood flows more easily through the body. In the brain, it reduces norepinephrine signaling, which can improve focus and dampen hyperactivity.
How SSRIs Work Differently
SSRIs, or selective serotonin reuptake inhibitors, target an entirely different neurotransmitter: serotonin. They block a protein called the serotonin transporter on nerve cells, which normally reabsorbs serotonin from the gap between neurons. By blocking that reabsorption, SSRIs keep more serotonin available in the brain for a longer period. This is the basis for their use in treating depression and anxiety disorders.
SSRIs have little effect on other neurotransmitter systems like norepinephrine or dopamine, which is part of why they tend to cause fewer side effects than older antidepressants. Common SSRIs include fluoxetine (Prozac), sertraline (Zoloft), and escitalopram (Lexapro). Guanfacine, by contrast, has no meaningful effect on serotonin at all.
Why People Confuse Them
The confusion likely comes from the fact that guanfacine is sometimes prescribed alongside psychiatric medications, or used off-label for anxiety-related symptoms. Research in animal models has shown that drugs in guanfacine’s class can have mood-related effects and may even enhance the effectiveness of SSRIs when the two are combined. But having complementary effects doesn’t make them the same type of drug. Guanfacine modulates norepinephrine; SSRIs modulate serotonin. They act on different receptors, through different mechanisms, for largely different conditions.
Different Side Effects to Expect
Because guanfacine and SSRIs affect different systems, their side effects look quite different. Guanfacine’s most noticeable effects relate to blood pressure and energy levels. Common side effects include drowsiness, dizziness, dry mouth, fatigue, and decreased appetite. Because it lowers blood pressure, standing up too quickly can cause lightheadedness or even fainting. It can also slow heart rate.
SSRIs, on the other hand, more commonly cause nausea, sexual dysfunction, weight changes, insomnia or excessive sleepiness, and emotional blunting. They don’t typically lower blood pressure or cause the kind of sedation guanfacine does.
One important difference with guanfacine: stopping it suddenly can cause a rebound spike in blood pressure along with nervousness and anxiety. This means doses need to be tapered gradually under medical guidance rather than stopped all at once. SSRIs also require gradual tapering but for different reasons, mainly to avoid discontinuation symptoms like dizziness, irritability, and brain zaps.
When Each One Is Used
Guanfacine is primarily used for ADHD and high blood pressure. In ADHD treatment, it’s often considered when stimulant medications aren’t well tolerated or when additional help with impulsivity and hyperactivity is needed. It’s not a first-line treatment for depression or anxiety.
SSRIs are the most widely prescribed class of antidepressants and are also used for generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder. They are not used for ADHD or blood pressure management.
In some cases, a person might take both a guanfacine and an SSRI if they have co-occurring conditions like ADHD and depression. The two drugs don’t compete for the same receptors, which is part of why they can be used together. But they remain fundamentally different medications treating different problems through different pathways in the brain.